Medical/Pharmaceuticals
Boehringer Ingelheim launches VETMEDIN® Solution (pimobendan oral solution), first oral solution approved by the FDA for congestive heart failure in dogs
* Heart disease in dogs is almost as common as it is in humans, affecting approximately 10 percent of dogs in their lifetime1 * Previous studies have shown that VETMEDIN® could help improve the survival time and quality of life for dogs with congestive heart failure due to myxomatous mitral v...
2024-11-23 05:09
1256
International Genomics Conference (ICG-19) Opens at BGI Group HQ in Shenzhen
SHENZHEN, China, Nov. 22, 2024 /PRNewswire/ -- The 19th Annual Meeting of the International Conference on Genomics (ICG-19) officially opened at BGI Group's Global Headquarters inShenzhen. This annual event brings together over 100 leaders in the field of genomics from the U.S., UK,Denmark, Austr...
2024-11-22 21:57
2135
FDA Granted Orphan Drug Designation of LBL-024, An Anti-PD-L1/4-1BB Bispecific Antibody Developed by Leads Biolabs, for Treatment of Neuroendocrine Cancer
NANJING, China, Nov. 22, 2024 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. (hereinafter referred to as "Leads Biolabs") announced that LBL-024, an anti-PD-L1/4-1BB bispecific antibody independently developed by the company with global intellectual property rights for the treatment of neuroendo...
2024-11-22 16:00
1883
Two In Vitro Studies on Eravacycline (XERAVA®) Presented at IDWeek, Demonstrating Its Sustained and Robust Antimicrobial Activity
SHANGHAI, Nov. 22, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that data on its critical-care, anti...
2024-11-22 12:14
1383
Olverembatinib Surmounts Ponatinib and Asciminib Resistance and Is Well Tolerated in Patients With CML and Ph+ ALL: New Report in JAMA Oncology
ROCKVILLE, Md. and SUZHOU, China, Nov. 22, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, announced today that findings from a ph...
2024-11-22 10:27
1426
TELUS Mental Health Index: Mental health of workers in Australia hits four-year low, costing businesses up to 69 workdays of productivity annually per employee
New data reveals younger workers and those without savings face the highest mental health risks, while strong employer support can halve productivity losses SYDNEY, Nov. 22, 2024 /PRNewswire/ -- Today, TELUS Health released its TELUS Mental Health Index ("the Index") with reports that examine the...
2024-11-22 02:00
844
poLight ASA receives purchase order for TWedge® wobulator technical samples from a top tier consumer OEM customer
TØNSBERG, Norway, Nov. 22, 2024 /PRNewswire/ -- poLight ASA (OSE: PLT) today announced that the company has received a purchase order worth approximatelyNOK 500,000 to supply its TWedge® wobulator technical samples to a top tier consumer OEM customer for an AR/MR application. "Our customer inter...
2024-11-22 00:44
1141
TELUS Mental Health Index: Singapore's workforce faces growing mental health crisis, threatening productivity and physical health
New research reveals sharp declines in mental health scores reversing two years of modest but steady improvement SINGAPORE, Nov. 21, 2024 /PRNewswire/ -- Today, TELUS Health released its TELUS Mental Health Index (the "Index") with reports examining the mental health of employed people inSingapo...
2024-11-22 00:01
915
TELUS Mental Health Index: 40 per cent of workers in New Zealand have high mental health risk as productivity losses mount
Workers diagnosed with anxiety lose more than 68 working days of productivity per year, underscoring the economic impact ofNew Zealand's declining mental health scores AUCKLAND, New Zealand, Nov. 22, 2024 /PRNewswire/ - Today, TELUS Health released itsTELUS Mental Health Index ("the Index") with...
2024-11-22 00:00
819
SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024
Launch of new application enables global access to highly recognized solid tumor profiling assay BOSTON and ROLLE, Switzerland, Nov. 21, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology leader in data-driven medicine, announced the global launch of MSK-IM...
2024-11-21 18:30
978
3Shape A/S and Medit Corp. Reach Settlement in Patent Infringement Lawsuit
COPENHAGEN, Denmark, Nov. 21, 2024 /PRNewswire/ -- 3Shape A/S, a global innovator in digital dentistry with its market-leading intraoral (IOS) scanners, and Medit Corp, a leading provider of dental 3D scanners, today announced they have settled U.S. patent infringement litigation. Both companies...
2024-11-21 18:18
910
BioWorld by Clarivate Highlights Gaps in Women's Health Research and Investment in New Special Series
New seven-part series explores disparities in care, funding and innovation impacting half the world's population LONDON, Nov. 21, 2024 /PRNewswire/ -- BioWorld™ published by Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, has launched its new special series,'...
2024-11-21 16:00
972
APRIL Group Supports National Health Development in Riau Province, Indonesia
SINGAPORE, Nov. 21, 2024 /PRNewswire/ -- Leading pulp, paper and board producer APRIL Group has further strengthened its commitment to improving public health by donating essential medical equipment to a local health facility in Riau province inSumatra, Indonesia, close to where the company's man...
2024-11-21 13:36
1181
/C O R R E C T I O N -- Sky Labs/
In the news release, Sky Labs' Blood Pressure Monitoring Device Recognized for High Accuracy by the International Society of Hypertension, issued24-Oct-2024 by Sky Labs over PR Newswire, we are advised by the company that there are updates to the content. The complete, corrected release follows: ...
2024-11-21 08:00
888
Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias
– Kura to receive a $330 million upfront payment and up to $1.2 billion in total milestone payments, including$420 million in near-term milestone payments and opt-in right for solid tumors – – Companies to jointly develop and commercialize ziftomenib; 50/50 profit share in the U.S.; Kura to lead...
2024-11-21 06:00
1417
GBI Biomanufacturing Expands Capabilities with Automated Aseptic Fill-Finish for Drug Products
PLANTATION, Fla., Nov. 21, 2024 /PRNewswire/ -- GBI Biomanufacturing (GBI), one of the world's longest serving contract development and manufacturing organizations (CDMO), is pleased to announce the expansion of its Drug Product (DP)services, to include automated sterile fill and finish capabilit...
2024-11-21 01:00
997
SD Biosensor and the NCCD Discuss Cooperation Measures to Eradicate Infectious Diseases
* A team of officials from the National Center for Communicable Diseases, Mongolia (NCCD), had a tour around the Cheongju and Jeungpyeong Factories of SD Biosensor, aSouth Korea's global in-vitro diagnostics company, during their visit to Korea. * SD Biosensor introduced total diagnostic plat...
2024-11-20 12:44
1057
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
SINGAPORE, Nov. 20, 2024 /PRNewswire/ -- Philips (NYSE: PHG, AEX: PHIA), a
global leader in health technology, andEdith Cowan University Australia (ECU)
2024-11-20 09:00
4870
Samsung Biologics signs manufacturing deal with European pharmaceutical company
* The company will provide manufacturing services through 2031 in deals worth overUSD 668 million * Samsung Biologics' cumulative contract value for 2024 surpasses USD 4 billion with latest deals INCHEON, South Korea, Nov. 20, 2024 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a global ...
2024-11-20 07:23
1210
Alamar Biosciences Announces Collaboration with The Michael J. Fox Foundation to Advance Parkinson's Research Through Development of Next Generation Biomarker Assays
FREMONT, Calif., Nov. 19, 2024 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is pleased to announce a strategic collaboration with The Michael J. Fox Foundation for Parkinson's Research (MJFF) to accelerate biomarker disco...
2024-11-19 22:12
1184
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
5310
